Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystadenocarcinoma, Serous | 3 | 2024 | 458 | 0.980 |
Why?
|
Fallopian Tubes | 3 | 2024 | 174 | 0.940 |
Why?
|
Ovarian Neoplasms | 5 | 2024 | 4808 | 0.690 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2020 | 194 | 0.590 |
Why?
|
Peripheral Nerves | 1 | 2020 | 466 | 0.560 |
Why?
|
Neural Stem Cells | 1 | 2020 | 875 | 0.430 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2821 | 0.360 |
Why?
|
Epithelial Cells | 1 | 2020 | 3669 | 0.300 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3704 | 0.280 |
Why?
|
Pyrazines | 2 | 2021 | 1192 | 0.230 |
Why?
|
Anoikis | 1 | 2024 | 49 | 0.230 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2022 | 44 | 0.210 |
Why?
|
Norepinephrine | 1 | 2024 | 898 | 0.190 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2022 | 326 | 0.170 |
Why?
|
Pyrazoles | 2 | 2021 | 1985 | 0.170 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3755 | 0.170 |
Why?
|
Hemoglobin, Sickle | 1 | 2016 | 113 | 0.130 |
Why?
|
Mitosis | 1 | 2021 | 1192 | 0.130 |
Why?
|
Immunoassay | 1 | 2016 | 746 | 0.110 |
Why?
|
Neoplasms | 1 | 2020 | 21808 | 0.100 |
Why?
|
Trans-Activators | 1 | 2021 | 2851 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3435 | 0.080 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1055 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1183 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5594 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8422 | 0.070 |
Why?
|
Erythrocytes | 1 | 2016 | 2400 | 0.070 |
Why?
|
Neurons | 1 | 2023 | 9351 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13402 | 0.060 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2023 | 220 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5207 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16439 | 0.050 |
Why?
|
Substance P | 1 | 2023 | 334 | 0.050 |
Why?
|
Ovary | 1 | 2023 | 959 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11586 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17648 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13553 | 0.040 |
Why?
|
Humans | 8 | 2024 | 752341 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 376 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13165 | 0.030 |
Why?
|
Female | 4 | 2024 | 386053 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 20843 | 0.030 |
Why?
|
Drug Synergism | 1 | 2019 | 1735 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 16736 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1114 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2019 | 1129 | 0.030 |
Why?
|
Animals | 2 | 2023 | 166802 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3553 | 0.020 |
Why?
|
Survival Analysis | 1 | 2023 | 10177 | 0.020 |
Why?
|
DNA Damage | 1 | 2019 | 2407 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2486 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 21712 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5163 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 17958 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23233 | 0.010 |
Why?
|
Mice | 1 | 2023 | 80543 | 0.010 |
Why?
|
Concepts
(56)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_